490mg Myhep Lvir Ledipasvir Sofosbuvir Tablets

Myhep Lvir (Ledipasvir & Sofosbuvir) – Description & Benefits

Myhep Lvir is a combination medication containing Ledipasvir (90mg) and Sofosbuvir (400mg), used for the treatment of chronic Hepatitis C virus (HCV) infection. This antiviral drug works by inhibiting viral replication, helping to eliminate the Hepatitis C virus from the body and preventing liver damage, cirrhosis, and liver cancer. Myhep Lvir is a widely recommended direct-acting antiviral (DAA) therapy known for its high cure rates.

Key Benefits of Myhep Lvir:

1. Highly Effective HCV Treatment: Proven to cure Hepatitis C in most patients within 12 to 24 weeks.
2. Prevents Liver Complications: Reduces the risk of liver cirrhosis, liver failure, and hepatocellular carcinoma.
3. Well-Tolerated Therapy: Minimal side effects compared to older Hepatitis C treatments.
4. Oral Administration: Easy-to-take tablet form, eliminating the need for injections.
5. Clinically Approved & Trusted: Recommended by global health organizations for Hepatitis C treatment.

Specification / Additional Details

• Active Ingredients: Ledipasvir 90mg + Sofosbuvir 400mg
• Packaging Type: Blister Pack / Bottle
• Packaging Size: 28 Tablets per Bottle
• Brand: Myhep Lvir
• Manufactured By: Mylan Pharmaceuticals
• Country of Origin: India

For bulk orders, wholesale pricing, and dropshipping services, contact us today!